Home

LEWIS H BENDER

CIK 1238705 · President and CEO · last filed 2026-07-20

LEWIS H BENDER is a President and CEO who has filed 15 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for INTS, was dated Jul 20, 2026. Across all open-market trades the lifetime net is +$24.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $833.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$833.2K

Companies

3

Total Filings

15

Lifetime Open-Market Net

$24.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INTS President and CEO 118,549 $4.55 $539.4K $0 4 2026-07-20
INTERLEUKIN GENETICS INC (ILI) Delisted CHIEF EXECUTIVE OFFICE 201,136 — — $24.2K 6 2010-01-22
EMIS Chief Technology Officer 28,833 $10.19 $293.8K $0 4 2007-08-13

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-20 INTS Grant (A) — $0 EDGAR
2026-03-30 INTS Grant (A) +37,749 $230.6K EDGAR
2025-05-06 INTS Grant (A) — $0 EDGAR
2024-03-07 INTS Grant (A) — $0 EDGAR
2011-02-16 — Grant (A) — $0
2010-01-22 INTERLEUKIN GENETICS INC (ILI) Delisted Grant (A) — $0 EDGAR
2009-03-16 INTERLEUKIN GENETICS INC (ILI) Delisted Grant (A) +110,000 $29.7K EDGAR
2008-11-24 INTERLEUKIN GENETICS INC (ILI) Delisted Buy (P) +30,000 $7.7K EDGAR
2008-11-20 INTERLEUKIN GENETICS INC (ILI) Delisted Buy (P) +30,000 $12.3K EDGAR
2008-02-20 INTERLEUKIN GENETICS INC (ILI) Delisted Buy (P) +3,000 $4.2K EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.